Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhalation toxicity of dimethyl piperidinone.

A J O'Neill1, P E Ross, G S Elliott

  • 1E.I. duPont de Nemours and Company, Inc., Haskell Laboratory for Health and Environmental Sciences, 1090 Elkton Road, Newark, DE 19714, USA.

Toxicology
|December 31, 2002
PubMed
Summary

The 90-day inhalation study of dimethyl-2-piperidinone (DMPD) in rats found no adverse effects at 230 mg/m(3). Laryngeal changes occurred at 310 mg/m(3), but male rat kidney effects were not relevant to human health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selection of resistance by antimicrobial coatings in the healthcare setting.

The Journal of hospital infection·2020
Same author

Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide <i>In Vitro</i> and <i>In Vivo</i>.

Antimicrobial agents and chemotherapy·2017
Same author

Tert-butyl benzoquinone: mechanism of biofilm eradication and potential for use as a topical antibiofilm agent.

The Journal of antimicrobial chemotherapy·2016
Same author

Redox-active compounds with a history of human use: antistaphylococcal action and potential for repurposing as topical antibiofilm agents.

The Journal of antimicrobial chemotherapy·2014
Same author

Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ).

The Journal of antimicrobial chemotherapy·2013
Same author

Loss of function of the gdpP protein leads to joint β-lactam/glycopeptide tolerance in Staphylococcus aureus.

Antimicrobial agents and chemotherapy·2011

Area of Science:

  • Toxicology
  • Inhalation Toxicology
  • Risk Assessment

Background:

  • Dimethyl-2-piperidinone (DMPD) is a chemical mixture requiring toxicological evaluation.
  • Understanding DMPD's inhalation toxicity is crucial for occupational safety and environmental risk assessment.

Purpose of the Study:

  • To assess the subchronic inhalation toxicity of DMPD in rats following 90-day repeated exposures.
  • To determine the no-observed-effect level (NOEL) and identify potential target organs.

Main Methods:

  • Male and female rats were exposed to 0, 51, 230, or 310 mg/m(3) DMPD for 6 hours/day, 5 days/week for 90 days.
  • Evaluations included clinical signs, body weight, clinical pathology, tissue pathology, neurobehavior, neuropathology, and semen quality.
  • Histopathological examinations of the larynx, kidneys, and liver were conducted.

Related Experiment Videos

Main Results:

  • No adverse effects were observed at 230 mg/m(3).
  • Minimal laryngeal hyperplasia and cartilage degeneration/necrosis occurred at 310 mg/m(3).
  • Male rats showed alpha(2 mu)-globulin nephropathy, considered not relevant to humans; reversible hepatocellular hypertrophy occurred in both sexes at higher doses.

Conclusions:

  • The no-observed-effect level (NOEL) for DMPD inhalation in rats is 230 mg/m(3).
  • Laryngeal changes at 310 mg/m(3) were the basis for the NOEL.
  • Male rat-specific kidney effects are not considered adverse for human health risk assessment.